Semaglutide
Weight Management
/
Injection
/
Injection
SubMagna™, developed by PCCA, is designed to enhance the bioavailability of active pharmaceutical ingredients (specifically semaglutide) when administered sublingually. This means a higher percentage of the drug enters the bloodstream, making the treatment more effective.
ACTIVE INGREDIENTS
HOW TO USE
DISCLAIMER
This compounded medication is only available when the commercially available product is unavailable or when a prescriber determines that there is a clinically significant difference for the patient.
Medicine Information
Potential Benefits
Treament Protocol
Legal
Storage Instructions
Warnings
Manufacturer Info
How It Works
F.A.Q
References